Neuroscience Focus Areas:
Our other therapy areas

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}

      • This website is for UK Healthcare Professionals only

      Contact us

      Please complete the form below and a member of the Botox team will get back to you.

      Please fill in your details below only if you are a UK registered healthcare professional and would like to contact an AbbVie representative.

      Please enter First name
      Please enter Last name
      Please enter Role
      E-mail address is not valid
      Please enter Last name
      Please enter Hospital name
      Please enter Hospital postcode
      Please select one field.

      Please note that there may be certain circumstances where we contact you in relation to important AbbVie product or information which we are required to provide to you or your patients as a matter of law, or in order to comply with the obligations we owe to you or them. This type of communications does not constitute as promotional communication.

      You can withdraw your consent at any time by using the unsubscribe option in the email or contacting [email protected] For further information about AbbVie’s privacy practices, please refer to the AbbVie Privacy notice.

      Please select one field.


      Please refer to the AbbVie privacy notice here for more information on how AbbVie processes your personal data and your data privacy rights.

      *Denotes mandatory field

      Incorrect. Please try again.

      Please refer to the BOTOX® Summary of Product Characteristics for further information on adverse events, contraindications and special warnings and precautions for use.

       

      BOTOX® PRESCRIBING INFORMATION

       

      Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/

      Adverse events should also be reported to AbbVie on [email protected] 

       

      Date of preparation: April 2022. UK-BCM-220081.